Bastian Czogalla Department of Obstetrics and Gynecology University Hospital, Ludwig-Maximilian-University (LMU) Munich Biography Publications Institution JoVE Articles Bastian Czogalla has not added a biography. If you are Bastian Czogalla and would like to personalize this page please email our Author Liaison for assistance. Publications Nuclear Receptor Co-repressor NCOR2 and Its Relation to GPER with Prognostic Impact in Ovarian Cancer Journal of Cancer Research and Clinical Oncology. Sep, 2023 | Pubmed ID: 37131060 PLA2G7/PAF-AH As Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer International Journal of Molecular Sciences. Jan, 2023 | Pubmed ID: 36614323 A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape Biomedicines. Mar, 2022 | Pubmed ID: 35453575 AKR1C1/2 Inhibition by MPA Sensitizes Platinum Resistant Ovarian Cancer Towards Carboplatin Scientific Reports. Feb, 2022 | Pubmed ID: 35115586 The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine Cells. Sep, 2021 | Pubmed ID: 34571986 Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer As a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway Biomedicines. Jun, 2021 | Pubmed ID: 34206491 Breast Adipose Tissue Macrophages (BATMs) Have a Stronger Correlation with Breast Cancer Survival Than Breast Tumor Stroma Macrophages (BTSMs) Breast Cancer Research : BCR. Apr, 2021 | Pubmed ID: 33849622 Nuclear Enolase-1/ MBP-1 Expression and Its Association with the Wnt Signaling in Epithelial Ovarian Cancer Translational Oncology. Jan, 2021 | Pubmed ID: 33069100 β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation Frontiers in Endocrinology. 2020 | Pubmed ID: 33042017 Potential of Platinum-resensitization by Wnt Signaling Modulators As Treatment Approach for Epithelial Ovarian Cancer Journal of Cancer Research and Clinical Oncology. Oct, 2020 | Pubmed ID: 32681294 Cytoplasmic VDR Expression As an Independent Risk Factor for Ovarian Cancer Histochemistry and Cell Biology. Oct, 2020 | Pubmed ID: 32572587 M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis Cells. May, 2020 | Pubmed ID: 32429133 High Galectin-7 and Low Galectin-8 Expression and the Combination of Both Are Negative Prognosticators for Breast Cancer Patients Cancers. Apr, 2020 | Pubmed ID: 32290551 Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients International Journal of Molecular Sciences. Jun, 2019 | Pubmed ID: 31212758 Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients International Journal of Molecular Sciences. Dec, 2018 | Pubmed ID: 30597961 Cyclic Transcutaneous Bleeding After Repeated Cesarean Section Deliveries American Journal of Obstetrics and Gynecology. Aug, 2018 | Pubmed ID: 29548753 Vitamin D and VDR in Gynecological Cancers-A Systematic Review International Journal of Molecular Sciences. Nov, 2017 | Pubmed ID: 29113037 Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer Fabian Trillsch*1,2, Juliane Reichenbach*1, Bastian Czogalla1, Fabian Kraus1, Alexander Burges1, Sven Mahner1,2, Mirjana Kessler1,2 1Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilian-University (LMU) Munich, 2German Cancer Consortium (DKTK), Partner site Munich (LMU), a partnership between the German Cancer Research Center (DKFZ) and the University Hospital of LMU Munich JoVE 66467 암 연구학
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer Fabian Trillsch*1,2, Juliane Reichenbach*1, Bastian Czogalla1, Fabian Kraus1, Alexander Burges1, Sven Mahner1,2, Mirjana Kessler1,2 1Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilian-University (LMU) Munich, 2German Cancer Consortium (DKTK), Partner site Munich (LMU), a partnership between the German Cancer Research Center (DKFZ) and the University Hospital of LMU Munich JoVE 66467 암 연구학
